Mir-200c-3p contrasts pd-l1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of -catenin and c-myc

HIGHLIGHTS

• who: Eleni Anastasiadou et al. from the Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy have published the research work: MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of -Catenin and c-Myc, in the Journal: Cells 2021, x of /2021/
• what: The authors sought to investigate if chemotherapy and IR could influence the expression of miR-200c-3p and its target genes like the immune checkpoint and other oncogenes in a cohort of EOC patients` biopsies.
• how: Two-tailed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.